What is the Home Infusion Therapy Market Size?
The global home infusion therapy market size was estimated at USD 41.83 billion in 2025 and is anticipated to reach around USD 90.65 billion by 2035, expanding at a CAGR of 8.04% from 2026 to 2035.
Home Infusion Therapy Market Key Takeaways
- North America dominated the global home infusion therapy market with the largest market share of 55.93% in 2025.
- Asia pacific is projected to expand at the fastest CAGR during the forecast period.
- By products, the infusion pumps segment contributed the highest market share in 2025.
- By application, the Anti-infective segment captured the biggest market share in 2025.
Home Infusion Therapy Market Growth Factors
Home Infusion therapy has turned into a well-known aggravation ease therapy technique, particularly for sicknesses where oral drug is least compelling. In instances of gastrointestinal sicknesses, diabetes and disease related torment home infusion therapy is normal. In addition, home infusion therapy is similarly compelling in treating problems like cystic fibrosis and persistent drying out. Home infusion therapy cuts on regular emergency clinic visits and further develops medication adherence.
Home infusion therapy alludes to the cycle wherein patients get therapy at home through the organization of medications or biologicals through catheters and needles. Getting therapy at home rather than emergency clinics or medical care offices is a smart and more helpful choice for patients, further driving the requirement for home infusion therapy.
As per The International Agency for Research on Cancer (IARC), gauges on the worldwide malignant growth trouble have ascended to 19.3 million cases and 10 million disease passings in 2020, and that implies 1 out of 5 individuals creates disease during their lifetime, and 1 of every 8 men and 1 out of 11 ladies kick the bucket from the sickness. As per The International Diabetes Federation (IDF), roughly 463 million grown-ups (20-79 years) were living with diabetes in 2019, which is assessed to ascend to 700 million by 2045. Furthermore, diabetes caused 4.2 million passings overall in 2019.
Legislatures in non-industrial nations are making huge speculations to modernize medical services foundation, which is probably going to build admittance to medical care. This is supposed to expand the interest for home infusion therapy administrations. Ascend in predominance of persistent illnesses in non-industrial nations presents worthwhile open doors in the home infusion therapy market.
Home Infusion therapy direct medication intravenously and at times through other non-oral courses like subcutaneously and an epidural. The advantages of home infusion therapy administration patient can seek intravenous therapy from the solace of their home and it's advantageous for patients. These assistance market gives nursing and drug specialist who will screen the heath all day, every day. The experience of the medical attendant to regulate complex intravenous therapies and the drug specialist with a decent admittance to the most recent examination and conventions work with the doctor to furnish the most ideal that anyone could hope to find care alongside home infusion therapy administrations. The home infusion therapy has demonstrated protected, viable and less exorbitant when contrasted with the patient therapy in the medical clinic. Dietician work alongside the attendant and the doctor to meet the current and future need of the patient in view of various factors like weight, sensitivities, stomach related capability.
The market has offers types of assistance to portions like enemy of infective, endocrinology, hydration therapy, chemotherapy, enteral sustenance, parenteral nourishment, and specialty drugs. The counter infective portion overwhelmed the market for home infusion therapy in 2019. This is credited to the impressive number of methods performed for the organization of antifungal and anti-toxin drugs. It additionally lessens openness to patients with other clinic gained diseases
Change in way of life will help the development of home infusion therapy market. Furthermore, expansion in diabetic populace and decrease in therapy cost will likewise set off the development of this market. Many convoluted ailments and sicknesses can be treated with these home infusion therapies which will decrease the medical clinic stay, and subsequently diminish the expense of therapy too. Home mixture therapies are more secure since the organization of the medications is seen by doctors. This will likewise increase the development of this market. Repayment approaches of different public and confidential firms will likewise help the development of this market.
Different innovative progressions and send off of novel items will enhance the business development. Presentation of complex advancements in home consideration settings will give new therapy choices decreased dangers of diseases. Besides, improvement of shrewd home infusion pumps can forestall dosing blunders and increments patient security. Previously mentioned variables will drive the market development across the figure time span.
Developing commonness of clinic obtained contaminations is one of the main considerations that will emphatically impact the development of home infusion therapy market. As per European Center for Disease Prevention and Control (ECDC), 4.5 million individuals experienced nosocomial contamination in 2017. Home infusion therapy significantly diminishes the openness of patients to irresistible organic entities diminishing the spread of nosocomial sicknesses by the patients. Also, the expense adequacy of home infusion therapy contrasted with hospitalization will additionally support the business development.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 41.83 Billion |
| Market Size by 2035 | USD 90.65 Billion |
| Growth Rate from 2026 to 2035 | CAGR of 8.04% |
| Largest Market | North America |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product, Application, Route of Administration, End User, Geography |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segment Insights
Products Insights
The infusion pumps segment contributed the highest market share in 2025. As these pumps are generally liked for the conveyance of supplements and drugs. The accessibility of different items, for example, enteral, needle, multichannel, and peristaltic pumps further add to the section development. The rising interest for needles and wandering pumps attributable to the rising inclination for home medical services is additionally expected to add to the fragment development.
These days, smart pumps are broadly utilized as these pumps contain progressed elements, for example, scanner tag innovation, which helps in the confirmation of a patient's character and forestalls drug organization blunders. Needleless connectors are expected to enlist the most noteworthy CAGR over the gauge period. These connectors offer better security, empower smooth medical procedures, and help stick to great clinical practice (GCP), which adds to the development of the section.
Application Insights
The Anti-infective segment captured the biggest market share in 2025. This is credited to the significant number of strategies performed for the organization of antifungal and anti-toxin drugs. It additionally diminishes openness to patients with other emergency clinic procured contaminations.
Chemotherapy is assessed to be the quickest developing fragment over the estimate period. With the developing frequencies of malignant growth, the interest for pressure pumps is supposed to increment before long. Pumps utilized for chemotherapy at home are conservative, nonstop tension pumps that don't need a battery and can consequently be utilized for a more extended timeframe. With the assistance of these pumps, chemotherapy medications can be managed at the proper mixture speed and in the perfect sums.
Regional Insights
What is the U.S. Home Infusion Therapy Market Size?
The U.S. home infusion therapy market size was evaluated at USD 21.06 billion in 2025 and is predicted to be worth around USD 45.99 billion by 2035, rising at a CAGR of 8.12% from 2026 to 2035.
North America dominated the global home infusion therapy market with the largest market share of 55.93% in 2025. and this pattern is supposed to go on all through the estimate period. This can be ascribed to the rising R&D in the locale and the rising reception of new innovation in home infusion pumps. The rising requirement for long haul therapy for patients with specific circumstances is driving the provincial market. Advancement of substitute medical care settings and home mixture administrations and moving inclination from intense consideration to home consideration settings because of the minimal expense and upgraded patient versatility would support the development of this market before long.
U.S. Market Trends
The U.S. showed strong growth driven by rising chronic diseases such as diabetes, cancer, and gastrointestinal disorders. Increasing preference for cost-effective home-based care and reduced hospital stays supported adoption. Advanced healthcare infrastructure, favorable reimbursement policies, and expanding availability of infusion therapies further accelerated market expansion.
Asia pacific is projected to expand at the fastest CAGR during the forecast period. This is credited to rising patient mindfulness with respect to the advantages of home infusion therapy over in-medical clinic strategies and the developing predominance of diabetes in the locale. The developing geriatric populace and the ascent in ongoing illnesses in the locale are supposed to additional fuel the market development. As per the Times of India, around 75 million individuals beyond 60 years old years' experience the ill effects of some constant sickness in India, which could build the reception of home consideration administrations in the country.
India Market Trends
India witnessed growing demand due to increasing chronic disease burden and rising awareness of home healthcare services. Expansion of telehealth, e-pharmacies, and digital health platforms supported adoption. Demand for affordable treatment options, improving healthcare access, and a focus on preventive care further contributed to market growth.
How is Europe Advancing in the Home Infusion Therapy Market?
Europe is considered to be a significantly growing area, due to favorable government support, rapidly expanding healthcare infrastructure, and the growing geriatric population. People are becoming aware of remote monitoring, enabling healthcare professionals to assess patients' conditions at home. The increasing number of trained medical professionals also contributes to market growth.
Germany Market Trends
Germany experienced steady growth driven by advanced healthcare infrastructure and a strong emphasis on patient safety. Increasing adoption of personalized medicine and biologics supported demand for home-based infusion. The rising elderly population and collaboration between hospitals and home care providers further strengthened market expansion.
What Drives Growth in the Latin America Home Infusion Therapy Market?
Latin America is expected to grow at a notable CAGR in the foreseeable future, due to improving healthcare infrastructure and rising awareness of home-based treatments. The availability of favorable reimbursement policies and increasing investments in the healthcare sector propel the market.
Brazil Market Trends
Brazil showed consistent growth supported by improving healthcare infrastructure and rising chronic disease burden. Increasing demand for chemotherapy and anti-infective therapies boosted adoption. Expanding healthcare access and investments in modern treatment solutions further contributed to market development.
How is the Middle East and Africa Expanding in the Home Infusion Therapy Market?
The Middle East & Africa region is expected to grow at a considerable CAGR in the upcoming period. The increasing incidence of chronic diseases, awareness about efficient treatment methods, and government efforts to improve healthcare delivery systems have increased the demand for the healthcare industry. In addition to these factors, the expansion of the private healthcare sector, investment in technology, and decreased hospitalization are driving market growth.
Home Infusion Therapy Market Companies
- CVS/Coram
- Option Care Health
- BriovaRx/Diplomat (UnitedHealth Optum)
- PharMerica
- Fresenius Kabi
- ICU Medical, Inc.
- B. Braun Melsungen AG
- Baxter
- BD
- Caesarea Medical Electronics
- Smith's Medical
- Terumo Corporation
- JMS Co. Ltd.
- Others
Key Market Developments
- In April 2026, Soleo Health launched SoleoRare™, a dedicated rare disease specialty pharmacy focused on complex patient needs. The initiative integrated specialized clinical, patient support, and commercial teams to deliver clinician-led, patient-centered care for rare and ultra-rare disease populations.
(Source: https://www.globenewswire.com ) - In May 2025, Horizon Health Network, in collaboration with Roche Canada, the New Brunswick Extra-Mural Program, and ResearchNB, launched Canada's first at-home under-the-skin cancer immunotherapy in New Brunswick. The program is expected to reduce pressure on infusion clinics, increase treatment capacity, and potentially lower the overall costs per patient. (Source: https://www.ctvnews.ca )
Segments Covered in the Report
By Product
- Infusion Pumps
- Elastomeric
- Electromechanical
- Gravity
- Others
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
By Application
- Anti-infective
- Endocrinology
- Diabetes
- Others
- Hydration Therapy
- Athletes
- Others
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
- Others
By Route of Administration
- Intramuscular
- Subcutaneously
- Epidural
By End User
- Patients
- Nurse
- Hospitals
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Table Of Content
+1 804-441-9344
Schedule a Meeting